Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- Zia, Al Raza
- Study ID
- NCT01989013
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- biweekly intervention — OTHER10 step craniosacral therapy protocol through manual therapy at feet , thoracic diaphragm, neck and cranium
Study Details
We are studying \& researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.
Key Dates
- Start date
- Feb 28, 2014
- Status verified
- Jan 2025
- Primary completion
- Mar 31, 2025
- Completion
- Mar 31, 2025
Study Design
- Enrollment
- 5 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: biweekly interventionbiweekly intervention
Primary Outcome Measure
reduction in tremors due to Parkinson's disease in the patient [ Time Frame: 3 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Naturalmed therapy | Ann Arbor | Michigan | 48104 | - |
Find similar trials in Ann Arbor, MI
Related Studies
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePHASE3 · Recruiting · Hoffmann-La Roche · Birmingham, Alabama
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsRecruiting · Bayer · Phoenix, Arizona
- Physiological Brain Atlas DevelopmentRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- The Parkinson's Genetic Research StudyRecruiting · University of Washington · Atlanta, Georgia